Cleared Special

K221951 - Branchor Balloon Guide Catheter

K221951 is the FDA 510(k) clearance for Branchor Balloon Guide Catheter by Asahi Intecc Co., Ltd.. It is a Class 2 Neurology device (product code QJP) cleared through the Special 510(k) pathway after a 98-day FDA review.

K221951 · Asahi Intecc Co., Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2022
Decision
98d
Days
Class 2
Risk

K221951 is an FDA 510(k) clearance for the Branchor Balloon Guide Catheter. Classified as Catheter, Percutaneous, Neurovasculature (product code QJP), Class II - Special Controls.

Submitted by Asahi Intecc Co., Ltd. (Seto, JP). The FDA issued a Cleared decision on October 11, 2022 after a review of 98 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Asahi Intecc Co., Ltd. devices

Submission Details

510(k) Number K221951 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 05, 2022
Decision Date October 11, 2022
Days to Decision 98 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
50d faster than avg
Panel avg: 148d · This submission: 98d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code QJP Catheter, Percutaneous, Neurovasculature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
Definition To Provide Vascular Access To The Neurovasculature For Interventional Or Diagnostic Procedures
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Asahi Intecc USA, Inc.
Cynthia Valenzuela

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - QJP Catheter, Percutaneous, Neurovasculature

All 90
Devices cleared under the same product code (QJP) and FDA review panel - the closest regulatory comparables to K221951.
CEREGLIDE 71 Intermediate Catheter
K221930 · Cerenovus, Inc. · Mar 2023
CELLO II Balloon Guide Catheter
K223275 · Fuji Systems Corporation · Dec 2022
BENCHMARK BMX81 Access System
K221822 · Penumbra, Inc. · Nov 2022
Route 92 Medical Full Length 070 Access System
K222743 · Route 92 Medical, Inc. · Oct 2022
Millipede 088 Access Catheter
K214048 · Perfuze, Ltd. · Sep 2022
Benchmark BMX96 Access System
K213390 · Penumbra, Inc. · Aug 2022